NFE2L2 and hepatocellular carcinoma: Therefore, pharmacologic or genetic inhibition of NRF2 and Rb expression or activity in hepatocellular carcinoma cells BAL b/c nude mouse xenograft model treated with sorafenib could enhance the effects of ferroptosis (Louandre et al., 2015; Sun et al., 2016).